Patents by Inventor Violaine K. Harris

Violaine K. Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9657268
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Grant
    Filed: October 28, 2014
    Date of Patent: May 23, 2017
    Assignee: MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
    Inventors: Saud A. Sadiq, Violaine K. Harris
  • Patent number: 9328329
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodendroglial and neuronal cell types.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: May 3, 2016
    Assignee: Multiple Sclerosis Research Center of New York
    Inventors: Saud A. Sadiq, Violaine K. Harris
  • Publication number: 20150118198
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Application
    Filed: October 28, 2014
    Publication date: April 30, 2015
    Applicant: MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
    Inventors: Saud A. SADIQ, Violaine K. Harris
  • Publication number: 20150064145
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Application
    Filed: October 28, 2014
    Publication date: March 5, 2015
    Applicant: MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
    Inventors: Saud A. SADIQ, Violaine K. Harris
  • Publication number: 20140308745
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodendroglial and neuronal cell types.
    Type: Application
    Filed: December 23, 2013
    Publication date: October 16, 2014
    Applicant: Multiple Sclerosis Research Center of New York
    Inventors: Saud A. SADIQ, Violaine K. Harris
  • Patent number: 8642331
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: February 4, 2014
    Assignee: Multiple Sclerosis Research Center of New York
    Inventors: Saud A. Sadiq, Violaine K. Harris
  • Publication number: 20110236357
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Application
    Filed: June 9, 2011
    Publication date: September 29, 2011
    Applicant: MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
    Inventors: Saud A. Sadiq, Violaine K. Harris
  • Publication number: 20100166712
    Abstract: Methods are provided for treating and/or reducing the severity of multiple sclerosis in a human, by administering autologous mesenchymal stem cell-derived neural precursors. Also described is an in vitro method for differentiating mesenchymal stem-cell derived neural precursor oligodengroglial and neuronal cell types.
    Type: Application
    Filed: November 2, 2007
    Publication date: July 1, 2010
    Applicant: MULTIPLE SCLEROSIS RESEARCH CENTER OF NEW YORK
    Inventors: Saud A. Sadiq, Violaine K. Harris